American Capital Advisory, LLC Blueprint Medicines Corp Transaction History
American Capital Advisory, LLC
- $185 Billion
- Q1 2025
A detailed history of American Capital Advisory, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, American Capital Advisory, LLC holds 3 shares of BPMC stock, worth $268. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3Holding current value
$268% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
390Shares Held
61.5MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$606 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$595 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$508 Million0.06% of portfolio
-
State Street Corp Boston, MA2.5MShares$224 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL1.94MShares$174 Million0.44% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.34B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...